Seth Lederman
2020
In 2020, Seth Lederman earned a total compensation of $3.9M as Chief Executive Officer at Tonix Pharmaceuticals Holding, a 201% increase compared to previous year.
Compensation breakdown
| Bonus | $460,688 |
|---|---|
| Option Awards | $2,799,884 |
| Salary | $614,250 |
| Total | $3,874,822 |
Lederman received $2.8M in option awards, accounting for 72% of the total pay in 2020.
Lederman also received $460.7K in bonus and $614.3K in salary.
Rankings
In 2020, Seth Lederman's compensation ranked 2,955th out of 13,090 executives tracked by ExecPay. In other words, Lederman earned more than 77.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,955 out of 13,090 | 77th |
Division Manufacturing | 1,148 out of 5,621 | 80th |
Major group Chemicals And Allied Products | 427 out of 2,254 | 81st |
Industry group Drugs | 370 out of 1,954 | 81st |
Industry Pharmaceutical Preparations | 273 out of 1,459 | 81st |
Source: SEC filing on March 31, 2021.
Lederman's colleagues
We found two more compensation records of executives who worked with Seth Lederman at Tonix Pharmaceuticals Holding in 2020.
News
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M
April 15, 2024
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2022 pay falls 41% to $4.6M
March 17, 2023
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2021 pay jumps 99% to $7.7M
March 18, 2022
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2020 pay jumps 201% to $3.9M
March 31, 2021
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2019 pay slips 13% to $1.3M
March 30, 2020
Tonix Pharmaceuticals Holding CEO Seth Lederman's 2018 pay jumps 157% to $1.5M
March 18, 2019